Pharmaceutical market analytics for therapeutic equity: Data-Driven models for expanding access to essential medicines
Bibliographic record
Abstract
Equitable access to essential medicines remains one of the most pressing global health challenges of the twenty-first century. Despite scientific and technological advances in drug development, millions in low- and middle-income countries (LMICs) still face barriers to affordable and timely treatment. This gap between innovation and accessibility—often driven by fragmented data systems, weak regulatory infrastructures, and market inefficiencies—underscores the need for pharmaceutical market analytics as a strategic tool for achieving therapeutic equity. This manuscript explores how data-driven models can transform medicine availability, affordability, and distribution through predictive analytics, real-time demand forecasting, and adaptive pricing algorithms. By leveraging artificial intelligence (AI) and real-world data, market analytics can identify underserved populations, optimize supply chains, and inform fair pricing mechanisms. Furthermore, the paper proposes a framework for ethical and equitable pharmaceutical market intelligence that integrates analytics, policy, and governance to ensure transparency and sustainability. Case examples from global access initiatives, such as insulin distribution programs and the WHO Global Price Reporting Mechanism, illustrate how analytics can close existing equity gaps. Ultimately, this paper argues that the future of pharmaceutical access depends not only on innovation in science but also on innovation in data systems—where evidence-based analytics empower stakeholders to design inclusive and resilient health markets. The findings highlight the critical intersection between data science, policy, and ethics in achieving universal access to essential medicines. Keywords: Pharmaceutical Analytics, Therapeutic Equity, Market Access.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.008 | 0.028 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.001 | 0.002 |
| Bibliometrics | 0.002 | 0.002 |
| Science and technology studies | 0.001 | 0.002 |
| Scholarly communication | 0.005 | 0.006 |
| Open science | 0.002 | 0.003 |
| Research integrity | 0.003 | 0.004 |
| Insufficient payload (model declined to judge) | 0.009 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".